Gedea Biotech (Sweden)
Gedea Biotech is a spin out from Lund University and was founded in 2016 by three chemists and a gynaecologist. By a modern and scientific approach, the companys founders have made a smart innovation without antimicrobial properties that is gentle for the user and provides both quick relief and long-term cure. Gedea has run an ambitious clinical program in bacterial vaginosis and the lead product pHyph is now CE-marked for treatment of bacterial vaginosis, partnering and launch in Europe.
Basic Information
- Category: business
- Website: http://gedeabiotech.com/
Documented Facts
- Email: julie.brogren@gedeabiotech.com (No linked source recorded for this statement.)
- Founded: 2016 (No linked source recorded for this statement.)
Evidence and Sources
- Gedea Biotech (Sweden) — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Gedea Biotech (Sweden).
- Canonical profile: https://brandsource.ai/brands/gedea-biotech-sweden
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/gedea-biotech-sweden/json-ld
- Citation profile API: https://brandsource.ai/api/brands/gedea-biotech-sweden/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (80/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Gedea Biotech is a spin out from Lund University and was founded in 2016 by three chemists and a gynaecologist. By a modern and scientific approach, the companys founders have made a smart innovation without antimicrobial properties that is gentle for the user and provides both quick relief and long-term cure. Gedea has run an ambitious clinical program in bacterial vaginosis and the lead product pHyph is now CE-marked for treatment of bacterial vaginosis, partnering and launch in Europe.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.